Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics

News   May 09, 2017 | Original story from Oxford Genetics

 
Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics
 
 
 
 

RELATED ARTICLES

Easily Automate PK Assays for Human IgG Drugs in Preclinical Species

News

At AAPS NBC event, Lumigen produced a poster summarizing the use of their pipetting robot, Andrew which can measure IgG drug concentration in a pre-clinical setting.

READ MORE

CRISPR Used to Prevent Development of Angiogenesis of the Retina

News

Powerful new technology may lead to novel therapies to prevent vision loss, blindness in those with diseases of the retina.

READ MORE

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE